FDA Implements Temporary Guidance for Neonatal Nutrition Compounding

The FDA has released immediate guidance for compounding specific starter parenteral nutrition products for neonates. This policy addresses regulatory priorities for outsourcing facilities and pharmacies, aiming to ensure continued access to these critical products following an anticipated market exit by a primary supplier.